Literature DB >> 22226058

Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.

Ken-Pen Weng1, Kai-Sheng Hsieh, Shih-Hui Huang, Shan-F Ou, Chun-Yen Ma, Tsyr-Yuh Ho, Chung-Ren Lai, Luo-Ping Ger.   

Abstract

We aimed to investigate which factors are associated with coronary artery lesions (CALs) during the acute and chronic stages in Taiwanese children with Kawasaki disease (KD). A total of 216 children with KD were enrolled. Clinical and laboratory data were obtained for each child within 7 days of illness. The patients were classified into KD children without acute CALs (n=135) and those with acute CALs (n=81) according to echocardiography data at Week 2 after treatment. Then, KD children with acute CALs were further divided into those without chronic CALs (n=55) and with chronic CALs (n=26) according to annual echocardiography data. During acute stage of KD, neutrophil count (<54%) [odds ratio (OR)=0.44, p=0.041]; second dose of intravenous immunoglobulin (IVIG) treatment (OR=5.01, p=0.009); and platelet count (≤400,000) (OR=0.42, p=0.006) were correlated with the risk of acute CALs. During chronic stage of KD, age (12-60 months) (OR=0.25, p=0.042); first dose of IVIG treatment (OR=0.12, p=0.005); and band count (≥3%) (OR=3.51, p=0.032) were correlated with the risk of chronic CALs. Our results suggest that the effects of neutrophil count, doses of IVIG treatment, and platelet count on CALs in acute KD are important. Age, doses of IVIG treatment, and band count are related to the persistence of CALs in chronic stage of KD.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226058     DOI: 10.1016/j.kjms.2011.09.002

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  9 in total

1.  Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.

Authors:  Lorna Stemberger Maric; Ivica Knezovic; Neven Papic; Branko Mise; Srdan Roglic; Leo Markovinovic; Goran Tesovic
Journal:  Rheumatol Int       Date:  2014-11-28       Impact factor: 2.631

2.  Acute Kawasaki disease with emphasis on the echocardiographic profile: A single center experience.

Authors:  Hala S Hamza; Wessam A Raouf; Asmaa Z Zaher; Hala M Agha
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

3.  Kawasaki disease in children and adolescents: clinical data of Kawasaki patients in a western region (Tyrol) of Austria from 2003-2012.

Authors:  Elisabeth Binder; Elke Griesmaier; Thomas Giner; Michaela Sailer-Höck; Juergen Brunner
Journal:  Pediatr Rheumatol Online J       Date:  2014-09-02       Impact factor: 3.054

4.  Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis.

Authors:  Fan Yan; Bo Pan; Huichao Sun; Jie Tian; Mi Li
Journal:  Front Pediatr       Date:  2019-09-26       Impact factor: 3.418

5.  MiR-182-5p enhances in vitro neutrophil infiltration in Kawasaki disease.

Authors:  Sung-Chou Li; Lien-Hung Huang; Kuang-Jen Chien; Chao-Yu Pan; Pei-Hsien Lin; Yuyu Lin; Ken-Pen Weng; Kuo-Wang Tsai
Journal:  Mol Genet Genomic Med       Date:  2019-10-11       Impact factor: 2.183

6.  Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19.

Authors:  Kuang-Den Chen; Ying-Hsien Huang; Wei-Sheng Wu; Ling-Sai Chang; Chiao-Lun Chu; Ho-Chang Kuo
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

Review 7.  Can Coronary Artery Involvement in Kawasaki Disease be Predicted?

Authors:  Sunil J Ghelani; Neha S Kwatra; Christopher F Spurney
Journal:  Diagnostics (Basel)       Date:  2013-03-26

8.  Myocardial Assessment in School-Aged Children with Past Kawasaki Disease.

Authors:  Heeyoung Lee; Jaeeun Shin; Lucy Eun
Journal:  J Korean Med Sci       Date:  2017-11       Impact factor: 2.153

9.  Cardiopulmonary Function, Exercise Capacity, and Echocardiography Finding of Pediatric Patients With Kawasaki Disease: An Observational Study.

Authors:  Sheng-Hui Tuan; Min-Hui Li; Miao-Ju Hsu; Yun-Jeng Tsai; Yin-Han Chen; Tin-Yun Liao; Ko-Long Lin
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.